Mel C. Schroeder

983 total citations
17 papers, 650 citations indexed

About

Mel C. Schroeder is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mel C. Schroeder has authored 17 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Mel C. Schroeder's work include Cancer therapeutics and mechanisms (3 papers), Synthesis and Biological Evaluation (3 papers) and Chemical Synthesis and Analysis (2 papers). Mel C. Schroeder is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Synthesis and Biological Evaluation (3 papers) and Chemical Synthesis and Analysis (2 papers). Mel C. Schroeder collaborates with scholars based in United States, Canada and China. Mel C. Schroeder's co-authors include John S. Kiely, Charles J. Stankovic, Sheila H. DeWitt, Dervil Cody, Michael R. Pavia, James M. Hamby, Wayne D. Klohs, H. D. Hollis Showalter, Sheila Crean and Denise L. Driscoll and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Mel C. Schroeder

16 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mel C. Schroeder United States 10 415 350 63 61 60 17 650
Wasyl Halczenko United States 13 448 1.1× 352 1.0× 48 0.8× 18 0.3× 72 1.2× 49 1.0k
Daniel H. O’Donovan United Kingdom 16 451 1.1× 301 0.9× 31 0.5× 55 0.9× 138 2.3× 27 833
Gunnar J. Hanson United States 18 556 1.3× 339 1.0× 26 0.4× 42 0.7× 56 0.9× 37 834
Damian W. Young United States 18 624 1.5× 533 1.5× 81 1.3× 34 0.6× 53 0.9× 48 953
Malin Lemurell Sweden 12 402 1.0× 184 0.5× 60 1.0× 20 0.3× 49 0.8× 15 587
Mark L. Peterson United States 9 604 1.5× 554 1.6× 112 1.8× 25 0.4× 78 1.3× 14 1.0k
Baudouin Gerard United States 14 617 1.5× 480 1.4× 60 1.0× 18 0.3× 49 0.8× 20 970
Valério Berdini United Kingdom 13 564 1.4× 292 0.8× 71 1.1× 44 0.7× 98 1.6× 22 899
Gregory A. Rener United States 11 285 0.7× 336 1.0× 53 0.8× 60 1.0× 93 1.6× 20 596
Darin E. Jones United States 20 297 0.7× 373 1.1× 39 0.6× 38 0.6× 69 1.1× 44 796

Countries citing papers authored by Mel C. Schroeder

Since Specialization
Citations

This map shows the geographic impact of Mel C. Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel C. Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel C. Schroeder more than expected).

Fields of papers citing papers by Mel C. Schroeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel C. Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel C. Schroeder. The network helps show where Mel C. Schroeder may publish in the future.

Co-authorship network of co-authors of Mel C. Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Mel C. Schroeder. A scholar is included among the top collaborators of Mel C. Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mel C. Schroeder. Mel C. Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dong, Steven D., Chin‐Chung Lin, & Mel C. Schroeder. (2013). Synthesis and evaluation of a new phosphorylated ribavirin prodrug. Antiviral Research. 99(1). 18–26. 9 indexed citations
2.
3.
Klein, Cheri E., et al.. (2004). Effect of atrasentan (ABT-627, ATN) on the pharmacokinetics (PK) of fexofenadine (FEX). Journal of Clinical Oncology. 22(14_suppl). 4723–4723. 3 indexed citations
4.
Schroeder, Mel C., James M. Hamby, Cleo J. C. Connolly, et al.. (2001). Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity. Journal of Medicinal Chemistry. 44(12). 1915–1926. 49 indexed citations
5.
Dimitroff, Charles J., Wayne D. Klohs, Amarnath Sharma, et al.. (1999). Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy. Investigational New Drugs. 17(2). 121–135. 71 indexed citations
6.
Connolly, Cleo J. C., James M. Hamby, Mel C. Schroeder, et al.. (1997). Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(18). 2415–2420. 58 indexed citations
7.
DeWitt, Sheila H., et al.. (1994). DIVERSOMERTM technology: Solid phase synthesis, automation, and integration for the generation of chemical diversity. Drug Development Research. 33(2). 116–124. 20 indexed citations
8.
DeWitt, Sheila H., John S. Kiely, Charles J. Stankovic, et al.. (1993). "Diversomers": an approach to nonpeptide, nonoligomeric chemical diversity.. Proceedings of the National Academy of Sciences. 90(15). 6909–6913. 252 indexed citations
9.
Domagala, John M., Susan E. Hagen, John S. Kiely, et al.. (1993). Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1-pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy. Journal of Medicinal Chemistry. 36(7). 871–882. 48 indexed citations
10.
Woolf, Thomas F., W F Pool, Susan M. Bjorge, et al.. (1993). Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.. Drug Metabolism and Disposition. 21(5). 874–882. 54 indexed citations
11.
Schroeder, Mel C., John S. Kiely, Edgardo Laborde, et al.. (1992). Synthesis of the four stereoisomers of several 3‐(1‐aminoethyl)pyrrolidines. Important intermediates in the preparation of quinolone antibacterials. Journal of Heterocyclic Chemistry. 29(6). 1481–1498. 7 indexed citations
12.
Laborde, Edgardo, et al.. (1991). Novel 7‐substituted quinolone antibacterial agents. Synthesis of 7‐alkenyl, cycloalkenyl, and 1,2,3,6‐tetrahydro‐4‐pyridinyl‐1,8‐naphthyridines. Journal of Heterocyclic Chemistry. 28(1). 191–198. 4 indexed citations
13.
14.
Kiely, John S., et al.. (1988). New "ofloxacin" type antibacterial agents. Incorporation of the spiro cyclopropyl group at N-1. Journal of Medicinal Chemistry. 31(10). 2004–2008. 14 indexed citations
15.
Schroeder, Mel C. & John S. Kiely. (1988). Synthesis of a novel tricyclic 4‐quinolone. Incorporation of a spiro‐cyclopropyl group at N1 by bridging to C2. Journal of Heterocyclic Chemistry. 25(6). 1769–1772. 13 indexed citations
16.
Reich, Hans J., Mel C. Schroeder, & Ieva L. Reich. (1984). Organoselenium Chemistry. Preparation of Allyl and Homoallyl Amines by Aminomethylation of Phenylseleno‐Substituted Allyl Tin Reagents. Israel Journal of Chemistry. 24(2). 157–161. 3 indexed citations
17.
Savage, Robert L., et al.. (1956). Solubility Phenomena in Dilute Alkyd Resin Solutions. Industrial & Engineering Chemistry. 48(10). 1956–1959. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wasyl Halczenko Breakdown of academic impact, for papers by Daniel H. O’Donovan Breakdown of academic impact, for papers by Gunnar J. Hanson Breakdown of academic impact, for papers by Damian W. Young Breakdown of academic impact, for papers by Malin Lemurell Breakdown of academic impact, for papers by Mark L. Peterson Breakdown of academic impact, for papers by Baudouin Gerard Breakdown of academic impact, for papers by Valério Berdini Breakdown of academic impact, for papers by Gregory A. Rener Breakdown of academic impact, for papers by Darin E. Jones
Rankless by CCL
2026